In fact, CD36 has been associated with obesity and diabetes in human diseases; Particularly, increased expression of hepatic CD36 is closely related to the development of NAFLD and non-alcoholic steatohepatitis (NASH) with insulin resistance [28]. This evidence concerns the gene CD36 and metabolic dysfunction-associated steatohepatitis.